Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Montara Therapeutics has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
Montara Therapeutics's investors include Dementia Discovery Fund, KdT Ventures, Michael J. Fox Foundation, Two Bear Capital, BEVC.
Montara Therapeutics is headquartered in San Francisco, United States.
Montara Therapeutics offers a platform to prevent peripheral toxicities and concentrate neurological drugs’ activity in the brain.
Montara Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Montara Therapeutics — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/montara-therapeutics. Accessed August 14, 2026.
VCBacked. (2026). Montara Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/montara-therapeutics
{{cite web |title=Montara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/montara-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated